Literature DB >> 773334

Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases.

H L Jenssen, H Köhler, J Günther, B Klausch, W Straube, R Hofmann, H H Büttner.   

Abstract

All patients examined [52] with malignant disease of the female genital tract showed lymphocyte reactions to encephalitogenic factor (EF) of more than 10% as measured by the macrophage electrophoretic mobility (MEM) test and its modification (MOD-MEM). Whilst 13 patients with non-malignant disease of the genital tract and 30 normals showed lymphocyte reaction to EF of less than 6%, 4 patients with nonmalignant gynaecological disease gave values above the 10% limit. The lymphocyte reactions of this latter group of patients were discussed with respect to their previous clinical histories. Some of the malignant cases were carcinoma of the cervix in situ so that the MEM test would appear to be of value in the early diagnosis of cancer. The need for caution in the interpretation of results is discussed as well as further possible applications of the technique.

Entities:  

Mesh:

Year:  1976        PMID: 773334     DOI: 10.1007/bf00667747

Source DB:  PubMed          Journal:  Arch Gynakol        ISSN: 0003-9128


  24 in total

1.  The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.

Authors:  R Jenssen; H L Jenssen; H Köhler; H Friemel
Journal:  Mod Probl Ophthalmol       Date:  1976

2.  Electrophoretic mobility, rosette formation and surface immunoglobulins of gradient fractionated human blood lymphocytes.

Authors:  N Sabolović; D Sabolović; F Dumont; G Siest
Journal:  Biomedicine       Date:  1974-02

3.  [Application and significance of macrophage-electrophoretic-mobility-test (MEM) in neurological diseases (author's transl)].

Authors:  H Meyer-Rienecker; H L Jenssen; H Köhler; J Günther; H J Gundlach
Journal:  Klin Wochenschr       Date:  1974-05-15

4.  The macrophage electrophoretic migration test in cancer.

Authors:  A H Goldstone; L Kerr; W J Irvine
Journal:  Clin Exp Immunol       Date:  1973-07       Impact factor: 4.330

5.  Macrophage-electrophoretic-mobility (M.E.M.) test for malignant disease. An independent confirmation.

Authors:  J A Pritchard; J L Moore; W H Sutherland; C A Joslin
Journal:  Lancet       Date:  1972-09-23       Impact factor: 79.321

6.  Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.

Authors:  J A Pritchard; J L Moore; W H Sutherland; C A Joslin
Journal:  Br J Cancer Suppl       Date:  1973-08

7.  Antigen solubilized from human leukemia: lymphocyte stimulation.

Authors:  J U Gutterman; G Mavligit; K B McCredie; G P Bodey; E J Freireich; E M Hersh
Journal:  Science       Date:  1972-09-22       Impact factor: 47.728

8.  The mechanism of action of macrophage migration inhibitory factor (MIF).

Authors:  E Pick; S Manheimer
Journal:  Int Arch Allergy Appl Immunol       Date:  1973

9.  Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia?

Authors:  E A Caspary; E J Field
Journal:  Br Med J       Date:  1971-06-12

10.  Lymphocyte sensitization in advanced malignant disease: a study of serum lymphocyte depressive factor.

Authors:  E J Field; E A Caspary
Journal:  Br J Cancer       Date:  1972-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.